Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.57 |
| ▸ | KCNK3 | O14649 | 6/20 | 0.57 |
| ▸ | KCNK9 | Q9NPC2 | 6/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | NT5E | P21589 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28448195 | 0.89 | MEN1 (0.57) | MEN1KMT2AKCNK3KCNK9POLB | |
| SCHEMBL29707145 | 0.89 | MEN1 (0.57) | MEN1KMT2AKCNK3KCNK9POLB | |
| SCHEMBL28408346 | 0.85 | MEN1 (0.45) | MEN1KMT2AKCNK3KCNK9POLB | |
| SCHEMBL393417 | 0.80 | ALDH1A1 (0.48) | MEN1KMT2AKCNK3KCNK9SMN1; SMN2 | |
| SCHEMBL2154879 | 0.79 | NPC1 (0.52) | MEN1KMT2APOLBSMN1; SMN2NPC1 | |
| SCHEMBL4853047 | 0.79 | NPC1 (0.61) | MEN1KMT2APOLBSMN1; SMN2NPC1 | |
| SCHEMBL20052984 | 0.79 | KMT2A (0.54) | MEN1KMT2AKCNK3KCNK9POLB | |
| SCHEMBL12076823 | 0.79 | KMT2A (0.56) | MEN1KMT2APOLBSMN1; SMN2NPC1 | |
| SCHEMBL259666 | 0.79 | KCNK3 (0.87) | MEN1KMT2AKCNK3KCNK9POLB | |
| SCHEMBL30608967 | 0.79 | KCNK3 (0.87) | MEN1KMT2AKCNK3KCNK9POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113264899-B | 1,3,5-oxadiazine compound and preparation and application thereof | 台州学院 | 2022-06-14 | — | — | CN | disclosed |
| CN-113264899-A | 1,3,5-oxadiazine compound and preparation and application thereof | 台州学院 | 2021-08-17 | — | — | CN | disclosed |
| US-10381580-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-08-13 | — | — | US | disclosed |
| US-20180151816-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-31 | — | — | US | disclosed |
| US-9947880-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10381580-B2 | Organic electroluminescent materials and devices | TEC, EML4, TPR | MEN1 1189/4885KMT2A 1118/4885KCNK3 1776/4885 |
| US-20180151816-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | TEC, EML4, TPR | MEN1 1189/4885KMT2A 1118/4885KCNK3 1776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.